Chargement en cours...
Multiple Sclerosis Medications in the VHA: Delivering Specialty, High-Cost, Pharmacy Care in a National System
INTRODUCTION/IMPORTANCE: Pharmacotherapy for multiple sclerosis has increased significantly since 1993 when the first disease modifying therapy was approved. The expansion of therapies has been accompanied with differences in adverse effect profiles, efficacy, and cost. The most recent therapies pos...
Enregistré dans:
| Publié dans: | Fed Pract |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontline Medical Communications Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7182246/ https://ncbi.nlm.nih.gov/pubmed/32341635 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|